Novo Nordisk said yesterday that it’s licensed a new obesity drug from The United Laboratories, a Chinese drugmaker.
The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi ... priced at a similar level to the glucagon injection kits available on the market, with a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback